Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Riboflavin-dependent oxidoreductase enzymes are a large family of flavoproteins that require the vitamin B₂-derived cofactors flavin adenine dinucleotide (FAD) or flavin mononucleotide (FMN) for their catalytic activity. These enzymes catalyze oxidation-reduction reactions essential for energy production, cellular respiration, antioxidant defense, and the metabolism of carbohydrates, lipids, proteins, drugs, and toxins. They play critical roles at metabolic branch points such as cholesterol and vitamin D biosynthesis. Deficiencies or mutations affecting these flavoenzymes can result in metabolic disorders impacting multiple organ systems including the nervous system and skeleton. The group includes well-known members such as glutathione reductase and various cytochrome P450 reductases but does not refer to one unique protein target. The term "Riboflavin-dependent oxidoreductase enzymes" is overly broad and refers to a large family of enzymes rather than a single, specific molecular target. It encompasses many different proteins with diverse biological roles. The class includes many enzymes, each with its own set of interacting drugs; no single drug interacts broadly with all riboflavin-dependent oxidoreductases. Mechanisms of action vary by specific enzyme; generally involve electron transfer via FAD or FMN cofactors from NAD(P)H to substrates, often as part of redox cycles. Glutathione reductase activity in red blood cells is used as a biomarker for riboflavin status, but not specifically for all riboflavin-dependent oxidoreductases. No general safety concerns apply to the entire class; individual enzymes may have therapeutic challenges depending on their role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Riboflavin-dependent oxidoreductase enzyme.